Current Grant Support
NIH/NIAID (U19 AI104317), “Identifying coronavirus B-cell epitopes associated with COVID-19 illness severity” Supplement to “Viral and environmental determinants of rhinovirus illness severity” (2020-2023). Seroogy, Co-Investigator
NIH/NIAID (U19 AI104317), “Human Epidemiology and Response to SARS-CoV-2 (HEROS)” Supplement to “Viral and environmental determinants of rhinovirus illness severity” (Sent2013-2023). Seroogy, Co-Investigator
NIH/Office of the Director (UG3 OD023282), “Children’s respiratory and environmental workgroup (CREW)” (2016-2023). Seroogy, Co-Investigator
NIH/NIAID (U19 AI104317), “Viral and environmental determinants of rhinovirus illness severity” (2013-2023). Seroogy, Project I Co-Investigator
NIH/NCATS (UL1 TR002373), “Institutional clinical and translational science award” (2017-2022). Seroogy, Assistant Director of the UW ICTR Clinical Research Unit
NIH/NIAID & Indiana University, “Lipid regulation of the development of responsiveness to allergen in neonates and infants” (2014-2022). Seroogy, Co-Investigator
Ira and Ineva Reilly Baldwin Wisconsin Idea Endowment, “Development and implementation of rapid genetic test to improve health outcomes in Wisconsin plain newborns” (2018-2021). Seroogy, PI
Wisconsin Partnership Program, “Integrated metabolomics, microbial genomics and immune profiling in early infancy to identify biomarkers for allergic disease prevention” (2018-2021). Seroogy, PI